Mydriacyl

— THERAPEUTIC CATEGORIES —
  • Miscellaneous ocular agents

Mydriacyl Generic Name & Formulations

General Description

Tropicamide 0.5%, 1%; oph soln; contains benzalkonium chloride.

Pharmacological Class

Anticholinergic.

How Supplied

Soln 0.5%—15mL; 1%—3mL, 15mL

Mydriacyl Indications

Indications

For mydriasis and cycloplegia for diagnostic procedures.

Mydriacyl Dosage and Administration

Adults and Children

For refraction: instill 1–2 drops of 1% soln in the eye(s); repeated in 5 minutes. An additional drop may be instilled if patient is not seen within 20–30 minutes. For examination of fundus: instill 1–2 drops of 0.5% soln 15 or 20 minutes prior to exam. Lacrimal sac should be compressed by digital pressure for 2–3 minutes after instillation to reduce excessive systemic absorption.

Mydriacyl Contraindications

Not Applicable

Mydriacyl Boxed Warnings

Not Applicable

Mydriacyl Warnings/Precautions

Warnings/Precautions

Remove contact lenses before use. Pregnancy (Cat.C). Nursing mothers.

Mydriacyl Pharmacokinetics

See Literature

Mydriacyl Interactions

Interactions

May interfere with antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Mydriacyl Adverse Reactions

Adverse Reactions

Ocular (eg, stinging, blurred vision, photophobia, superficial punctuate keratitis, transient elevation of intraocular pressure), dry mouth, tachycardia, headache, allergic reactions, GI upset, pallor, CNS disturbances (esp. in children).

Mydriacyl Clinical Trials

See Literature

Mydriacyl Note

Not Applicable

Mydriacyl Patient Counseling

See Literature